The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

SureCN1477725     [(3R,4R,5R)-2-(2-amino-6-oxo- 3H-purin-9...

Synonyms: AC1L3TVA, AR-1E1875, 2'-GMP, 2'-guanylic acid, 2'-Guanosine monophosphate
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of 2'-Guanosine monophosphate

 

High impact information on 2'-Guanosine monophosphate

  • The interactions in the active site of the present structure are compared to those found in the 2'-GMP complex of RNase T1 [2].
  • The binding of the mononucleotide inhibitors 2'-GMP, 3'-GMP, and 5'-GMP to genetically engineered ribonuclease T1 has been investigated by conventional inhibition kinetics, fluorimetric titrations, molecular modeling, and fast relaxation techniques [3].
  • The kinetics of binding are nearly diffusion controlled with a kon determined for 2'-GMP and 3'-GMP, as (5.0 +/- 0.5 x 10(9) and 6.1 +/- 0.5 x 10(9) M-1, s-1 and koff as 1.2 +/- 0.2 x 10(3) and 2.0 +/- 0.3 x 10(3) s-1, respectively [3].
  • The ribonuclease T1 variant 9/5 with a guanine recognition segment, altered from the wild-type amino acid sequence 41-KYNNYE-46 to 41-EFRNWQ-46, has been cocrystallised with the specific inhibitor 2'-GMP [4].
  • In two attempts to dock methotrexate to dihydrofolate reductase and 2'-GMP to ribonuclease T1, the exact structures of complexes in crystals were reproduced as the most stable docking models, without any assumptions concerning the binding modes and ligand conformations [5].
 

Chemical compound and disease context of 2'-Guanosine monophosphate

  • The crystal structure of a complex of ribonuclease from Streptomyces aureofaciens (RNase Sa) with guanosine-2'-monophosphate (2'-GMP) has been refined against synchrotron data recorded from a single crystal using radiation from beamline X31 at EMBL, Hamburg, and an imaging plate scanner [1].
 

Biological context of 2'-Guanosine monophosphate

  • The latter is indicated by the position of phosphate and sugar residues of 2'-GMP and shows that Glu58, His92 and Arg77 are active in phosphodiester hydrolysis [6].
 

Associations of 2'-Guanosine monophosphate with other chemical compounds

 

Gene context of 2'-Guanosine monophosphate

  • We present free energy perturbation calculations on the complexes of Glu46----Ala46 (E46A) and Glu46----Gln46 (E46Q) mutants of ribonuclease T1 (RNaseT1) with inhibitors 2'-guanosine monophosphate (GMP) and 2'-adenosine monophosphate (AMP) by a thermodynamic perturbation method implemented with molecular dynamics (MD) [11].
  • Activation enthalpies (kcal/mol) and entropies (eu) for 2'-GMP are: delta H not equal to = 18.5 +/- 1.3, delta S not equal to = 9.6 +/- 4.2 for TMA+ salt at pH 8.10, and delta H not equal to = 14.7 +/- 2.6, delta S not equal to = -3.7 +/- 8.0 for the Na+ salt at pH 8.11 [12].
 

Analytical, diagnostic and therapeutic context of 2'-Guanosine monophosphate

References

  1. Complex of ribonuclease from Streptomyces aureofaciens with 2'-GMP at 1.7 A resolution. Sevcik, J., Hill, C.P., Dauter, Z., Wilson, K.S. Acta Crystallogr. D Biol. Crystallogr. (1993) [Pubmed]
  2. Crystal structure of RNase T1 with 3'-guanylic acid and guanosine. Zegers, I., Haikal, A.F., Palmer, R., Wyns, L. J. Biol. Chem. (1994) [Pubmed]
  3. Modes of mononucleotide binding to ribonuclease T1. Georgalis, Y., Zouni, A., Zielenkiewicz, P., Holzwarth, J.F., Clarke, R., Hahn, U., Saenger, W. J. Biol. Chem. (1992) [Pubmed]
  4. Structural analysis of an RNase T1 variant with an altered guanine binding segment. Höschler, K., Hoier, H., Hubner, B., Saenger, W., Orth, P., Hahn, U. J. Mol. Biol. (1999) [Pubmed]
  5. Rational automatic search method for stable docking models of protein and ligand. Mizutani, M.Y., Tomioka, N., Itai, A. J. Mol. Biol. (1994) [Pubmed]
  6. Crystallographic study of mechanism of ribonuclease T1-catalysed specific RNA hydrolysis. Heinemann, U., Saenger, W. J. Biomol. Struct. Dyn. (1983) [Pubmed]
  7. Crystal structure of ribonuclease T1 carboxymethylated at Glu58 in complex with 2'-GMP. Ishikawa, K., Suzuki, E., Tanokura, M., Takahashi, K. Biochemistry (1996) [Pubmed]
  8. Phosphotyrosine phosphatase: a novel phosphatase specific for phosphotyrosine, 2'-AMP and p-nitrophenylphosphate in rat brain. Motoyama, N., Takimoto, K., Okada, M., Nakagawa, H. J. Biochem. (1987) [Pubmed]
  9. Modes of binding of 2'-AMP to RNase T1. A computer modeling study. Balaji, P.V., Saenger, W., Rao, V.S. J. Biomol. Struct. Dyn. (1992) [Pubmed]
  10. Zinc-ion-dependent acid phosphatase exhibits magnesium-ion-dependent myo-inositol-1-phosphatase activity. Fujimoto, S., Okano, I., Tanaka, Y., Sumida, Y., Tsuda, J., Kawakami, N., Shimohama, S. Biol. Pharm. Bull. (1996) [Pubmed]
  11. Relative binding free energy calculations of inhibitors to two mutants (Glu46----Ala/Gln) of ribonuclease T1 using molecular dynamics/free energy perturbation approaches. Hirono, S., Kollman, P.A. Protein Eng. (1991) [Pubmed]
  12. Structure sensitivity of amino proton exchange in 2'- and 5' - guanosine monophosphate dianions. Barr, R.G., Pinnavaia, T.J. J. Biomol. Struct. Dyn. (1994) [Pubmed]
  13. Crystallization of a complex between ribonuclease T1 and 2'-guanylic acid. Heinemann, U., Wernitz, M., Pähler, A., Saenger, W., Menke, G., Rüterjans, H. Eur. J. Biochem. (1980) [Pubmed]
 
WikiGenes - Universities